Skip to main content
2026 Prospectus
National Medical Dosimetrist’s Day 2026 executive healthcare observance hero.

· Executive Brief

National Medical Dosimetrist’s Day 2026

Move from recognition activity to a visible operating route with named owners and closed loops.

Greg Wahlstrom in his office at The Healthcare Executive
Written byMBAHCMPresident and Chief Executive Officer, The Healthcare ExecutiveOctober 2026 29 min read

Leadership signal

Use National Medical Dosimetrist’s Day to examine the system behind the message.

Leaders can use this window to test whether public information, service entry points, internal referrals, and follow-up responsibilities form one understandable route. The review should start with the experience of people using the system and the teams responsible for receiving them.

Start by distinguishing what is known from what the organization still needs to learn. A campaign plan, communication volume, or meeting count does not establish that a route is usable. Leaders need direct listening, clear ownership, locally defined measures, and a method for keeping exceptions visible.

Executive opening

Treatment planning is the hidden throughput system of radiation oncology

Every course of radiation therapy depends on a treatment plan built by medical dosimetrists, checked by physicists and approved by radiation oncologists. Patients rarely see this work, but it shapes how quickly treatment starts and how safely it is delivered. When planning queues grow, the delay reaches every patient waiting to begin.

Planning is labor-intensive and often manual. One breast radiation therapy quality improvement study covered 515 patients from 2020 to 2022.[1] Medical dosimetrist planning time fell from 8 (± 4) hours to 4 (± 1) hours after process redesign and automated planning, while plan quality was maintained.[1] Radiation oncologist contouring time stayed at 0.2 hours, so the gain came mainly from planning.[1] That difference shows how much capacity is tied up in workflow design rather than clinical judgment alone.

Automation is spreading quickly, but it does not remove the need for people. In an eight-department real-world evaluation, AI-assisted contouring reduced contouring time and redistributed workload across staff types.[2] Yet workflow design meant that time saving was not observed across the whole treatment planning pathway.[2] Gains in one step can disappear if the next handoff still waits. Executives who fund new tools therefore also need to fund the redesign of the pathway around them.

National Medical Dosimetrist Day is a practical moment for executives to look at planning as an operating system. That system includes workforce and training, workload and turnaround, plan checks and physics review, automation governance and measurement of errors and delays. The sections below summarize peer-reviewed evidence on each. They sit beside the executive guidance already on this page and do not offer clinical advice. The aim is a shared factual base for leaders who decide on staffing, tools and governance.

Current evidence

What the research says about planning workload and automation

Most current evidence on planning operations comes from studies of automation. In the National Health Service evaluation, data from 626 patients were collected across eight radiotherapy departments, comparing manual and AI-enabled pathways from planning scan to first treatment.[2] AI contours were generally well accepted, with 15.9% requiring no edits and 64.4% only minor edits.[2] Acceptability varied by anatomy, with breast contours performing best and prostate and head and neck contours needing more editing.[2]

Fully automated workflows show larger time effects but still need review. In a prospective blinded evaluation of 22 consecutive prostate patients, clinically acceptable results were achieved in 86% of fully automated cases compared with 95% for the conventional workflow.[3] Total preparation time decreased from 87 min to about 9 min.[3] The authors proposed a draft-first approach with mandatory physician review, noting that automated target volumes were consistently smaller.[3] Conventional plans were rated good more often (17/22 vs 12/22), mainly due to differences in target delineation.[3]

Complex treatment sites show similar patterns. A craniospinal irradiation workflow was trained on 91 patients and achieved dice coefficients of 0.93 for the target volume.[11] It reduced contouring time from 1–2 h to 10 min, and the knowledge-based plans met clinical targets while improving organ sparing.[11] However, those plans showed higher target hotspots and required more monitor units.[11] For head and neck planning, a study of 40 postoperative tongue cancer patients found that automated contouring took approximately 1.5 minutes per patient without editing and approximately 9 minutes with editing.[13]

Accuracy is not uniform across structures. In the tongue cancer study, parallel organs showed minimal dosimetric differences, but spinal cord maximum dose increased by 1.98 ± 2.70 Gy.[13] Target coverage remained excellent, with mean V95% of 97.75 ± 1.22% for the higher-dose target volume.[13] The authors concluded that serial organs require careful manual verification.[13] That finding defines a clear role for dosimetrists and physicians even when contours are generated automatically.

Taken together, the evidence suggests that automation can return substantial time to planning teams while shifting their work toward review, editing and judgment. In the NHS evaluation, AI tools created operational flexibility, but workflow design limited time savings across the whole pathway.[2] For a board, the practical takeaway is that each automation project should report review burden alongside time saved, so the full effect on staff is visible.

Figure 1

Automation drafts much of the work, but review still matters

Automation drafts much of the work, but review still mattersPercent of contours, plans or check time, as reported in each study. Values are copied from the cited studies [2], [3], [4]; none is estimated.0%25%50%75%100%AI-generated contours needing no editsAI-generated contours needing no edits: 15.9% (source [2])15.9%[2]AI-generated contours needing only minoreditsAI-generated contours needing only minor edits: 64.4% (source [2])64.4%[2]Fully automated prostate plansclinically acceptableFully automated prostate plans clinically acceptable: 86% (source [3])86%[3]Conventional prostate plans clinicallyacceptableConventional prostate plans clinically acceptable: 95% (source [3])95%[3]Reduction in plan check time with scriptassistanceReduction in plan check time with script assistance: 23.9% (source [4])23.9%[4]Source [2]Source [3]Source [4]Shade and hatching group bars by study; the studies differ in population and setting, so bars compare only within a shade

Percent of contours, plans or check time, as reported in each study. Values are copied from the cited studies [2], [3], [4]; none is estimated.

Data note. These values come from different studies, sites and measures, so this is an indirect comparison; the bars show how much automation drafts and how much review remains, not how one tool compares with another.

Limitation. Contour and plan acceptability depend on anatomy and local standards; the plan check reduction reflects one script in one department.

Figure data (5 rows)
Figure 1 data: Automation drafts much of the work, but review still matters
MeasureValuePopulation, setting and year as reportedSource
AI-generated contours needing no edits15.9%Eight NHS radiotherapy departments, 626 patients[2]
AI-generated contours needing only minor edits64.4%Same eight-department evaluation[2]
Fully automated prostate plans clinically acceptable86%22 consecutive prostate patients, blinded physician review at one center[3]
Conventional prostate plans clinically acceptable95%Same 22 patients, conventional workflow[3]
Reduction in plan check time with script assistance23.9%Four medical physicists checking nine clinical cases, randomized order[4]
A medical dosimetrist works at two monitors showing dose contours in a dim dosimetry office, coffee beside the keyboard.
Illustrative image. Medical dosimetrist planning time fell from 8 to 4 hours after process redesign in one breast program.[1]

Continuum of care

Where planning handoffs break between scan, plan, check and treatment

Planning is a chain of handoffs: simulation, contouring by physicians, planning by dosimetrists, physics checks, physician approval and patient-specific quality assurance. Each step has its own queue. The NHS evaluation found that 100% of manual contour reviews involved clinical oncologists, compared with 38% of reviews of AI-generated contours.[2] The authors suggested that pathway revision involving different staff types could address local bottlenecks.[2]

Physics review is another constraint. In a randomized comparison, four experienced medical physicists checked nine representative clinical cases with and without an automated plan check script.[4] Script-assisted checks reduced mean plan check time from 549.9 ± 52.5 s to 418.6 ± 48.8 s, an average reduction of 131.3 s (23.9%) per case.[4] The maximum reduction was about 4 min in complex cases such as electron therapy.[4] Saved minutes per plan add up across a busy department, especially when complex cases cluster.

Patient-specific quality assurance can also be targeted. A study using neural networks with machine log files and plan complexity indices found that log-file gamma passing rates exceeded experimental measurements (99.0% ± 0.8% vs. 95.9% ± 2.8%).[5] The correlation between the two was insufficient for standalone plan classification.[5] Combining complexity indices with log data achieved an average sensitivity of 0.70 ± 0.10 across 20 training sessions, suggesting a route to focus measurement on plans most likely to have delivery issues.[5] Maximum leaf travel per monitor unit, maximum gantry rotation and beam delivered energy were the strongest predictors.[5]

Coordination tools support the handoffs themselves. One department built an in-house platform with twelve modular tools that centralized patient data, schedules and task tracking.[6] One year after implementation, most tasks in the external beam workflow experienced a reduction in average duration.[6] Dosimetrists most often used the schedule, planning whiteboard, spreadsheet and workload tracking modules, which helped distribute tasks fairly.[6]

The common thread is visibility. When each step can see what is waiting, who owns it and when it is due, planning becomes a managed flow rather than a set of separate queues. Executives can ask whether their departments have that view today. Departments can pair these tools with an incident learning process, so that rework and near misses found during checks are fed back to planners rather than corrected silently.

Figure 3

Why the pathway breaks

Cause-and-effect diagram: Treatment plans are delayed or vary in quality between planning scan and first treatmentUnranked qualitative cause-and-effect diagram for the outcome in the box: Treatment plans are delayed or vary in quality between planning scan and first treatment Causes are assembled from the cited literature [1], [2], [3], [4], [5], [6], [7], [8], [13]; categories are not weighted and their order carries no meaning.Treatment plans are delayed orvary in quality betweenplanning scan and firsttreatmentPeopleProcessTechnologyEnvironmentPolicyMeasurement

People

  • Dosimetrist capacity not matched to case mix
  • Beginner planners without decision support
  • Physician and physicist review time concentrated in few roles

Process

  • Task sequence not redesigned when tools change
  • Time saved in contouring lost in later queues
  • No defined review rule for automated outputs

Technology

  • Knowledge-based models not retrained after upgrades
  • Automated contours less reliable for serial organs
  • Data and schedules held in separate systems

Environment

  • Network sites without shared models
  • High-volume settings with scarce specialists
  • Clustered complex cases

Policy

  • No governance for model ownership and validation
  • Quality assurance applied uniformly rather than by risk
  • Data security and compliance not built into local tools

Measurement

  • Turnaround not tracked from scan to first treatment
  • Plan quality not compared across sites and planners
  • Rework and near misses not captured

Unranked qualitative cause-and-effect diagram for the outcome in the box: Treatment plans are delayed or vary in quality between planning scan and first treatment Causes are assembled from the cited literature [1], [2], [3], [4], [5], [6], [7], [8], [13]; categories are not weighted and their order carries no meaning.

Data note. Qualitative; no frequencies are implied.

Limitation. Causes drawn from published studies may not all apply locally; validate them with frontline teams.

Figure data (6 rows)
Figure 3 data: Why the pathway breaks
CategoryCauses drawn from the cited literature
PeopleDosimetrist capacity not matched to case mix; Beginner planners without decision support; Physician and physicist review time concentrated in few roles
ProcessTask sequence not redesigned when tools change; Time saved in contouring lost in later queues; No defined review rule for automated outputs
TechnologyKnowledge-based models not retrained after upgrades; Automated contours less reliable for serial organs; Data and schedules held in separate systems
EnvironmentNetwork sites without shared models; High-volume settings with scarce specialists; Clustered complex cases
PolicyNo governance for model ownership and validation; Quality assurance applied uniformly rather than by risk; Data security and compliance not built into local tools
MeasurementTurnaround not tracked from scan to first treatment; Plan quality not compared across sites and planners; Rework and near misses not captured

Access

Extending high-quality planning beyond large centers

Access to radiation therapy depends on planning capacity as much as on treatment machines. Knowledge-based planning models normally require large libraries of past plans, which are hard to assemble in new or resource-limited centers.[12] A 2026 study generated synthetic dose distributions from target and organ geometry for 25 head-and-neck and 25 prostate cases.[12] Models trained on these synthetic doses maintained target coverage compared with models trained on 171 and 97 clinical cases.[12] The authors described the approach as a practical strategy for centers with limited planning resources.[12]

Shared models can travel across borders. A center in Guatemala adapted knowledge-based planning models originally built at a U.S. academic institution and refined them with 194 left-breast and 103 right-breast local cases.[15] In a retrospective analysis of 84 breast and chest wall plans, average planning target volume V95% was 97.3% ± 1.8% for right-sided and 96.6%±3.8% for left-sided plans.[15] Median heart mean dose was 2.4 Gy for right-sided and 4.2 Gy for left-sided plans.[15] The authors concluded that the approach supports more equitable access to radiotherapy for breast cancer patients.[15]

Automation can also lower labor cost in high-volume settings. A multi-center study across 18 oncology centers in a low- and middle-income country assessed 116 planning cases, with six physicians reviewing cases across multiple anatomical sites.[14] Mean time savings from automated contouring across all cases was 13.8 minutes.[14] After accounting for software costs, net savings ranged from INR 37 to INR 670 per case depending on clinician cost assumptions.[14]

Portability is a practical barrier for many health systems. A large language model refinement layer applied to 62 lung cancer cases raised clinical goal achievement from 79% to 98% for a publicly available knowledge-based model, without model-specific tuning.[9] Institutional models improved from 73% to 97% and from 69% to 98%, and a fixed template without any knowledge-based model rose from 68% to 97%.[9] Approaches like this could help network sites use shared models without building their own from scratch, although they remain early.

For executives, access means asking whether a patient treated at a community site receives a plan built with the same standards and tools as one treated at the flagship. Shared models, consistent review rules and planning support across sites are the operating levers. Shared models still need local validation before clinical use, and the Guatemala team validated its adapted models against a local clinical cohort.[15]

Executive guidance · System route

Connect the day to an accountable system route.

Use this route as a discussion framework. Replace each stage with the organization’s approved process, qualified roles, current service capacity, and applicable requirements. Do not infer a clinical protocol from the observance title.

The route at a glance

  1. Listen
  2. Clarify entry
  3. Coordinate the partner route
  4. Protect transitions
  5. Verify and learn

Reliability rule: Every stage needs a named owner, an observable status, an approved escalation path, and a defined signal that shows whether responsibility moved or remained unresolved.

  1. Listen

    Gather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions.

  2. Clarify entry

    Publish a plain-language first step and identify who receives requests through each approved channel.

  3. Coordinate the partner route

    Align internal teams and external partners around one current message, real entry point, receiving owner, escalation path, and follow-through signal.

  4. Protect transitions

    Use acknowledgment and status visibility when responsibility moves between services, locations, or organizations.

  5. Verify and learn

    Review unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals.

Figure 2

The system route as one flow

The system route as one flowThe five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.ListenClarify entryCoordinate thepartner routeProtecttransitionsVerify and learnLearning returns to the start of the route

The five stages of the system route described in this brief, drawn as one flow with a learning loop back to the start. The stages are the page’s original executive guidance, not a clinical protocol.

Data note. Shows sequence and handoffs only; it carries no counts or rates.

Limitation. Local processes may add, merge or reorder stages under organizational policy.

Figure data (5 rows)
Figure 2 data: The system route as one flow
StageWhat the stage requires
ListenGather questions and friction points from people using the route, frontline teams, and community-facing staff. Separate observed barriers from assumptions.
Clarify entryPublish a plain-language first step and identify who receives requests through each approved channel.
Coordinate the partner routeAlign internal teams and external partners around one current message, real entry point, receiving owner, escalation path, and follow-through signal.
Protect transitionsUse acknowledgment and status visibility when responsibility moves between services, locations, or organizations.
Verify and learnReview unresolved work, repeat contacts, and avoidable handoffs. Use the findings to improve the route rather than blame individuals.

Equity and trust

Consistency across sites and planners is an equity question

Equity in radiation oncology planning often appears as variation. Plans can differ by site, machine, software version and planner experience. A knowledge-based model built from 594 institutional plans was designed to standardize planning across connected radiotherapy sites.[10] It maintained target coverage while reducing oral cavity and larynx mean doses, and monitor units fell from 764.2 ± 275.5 to 695.8 ± 210.3.[10] The validation set included 370 plans from 289 patients, and no fully patient-independent validation cohort was available.[10] The authors described the model as a decision-support tool requiring expert review.[10]

Planner experience affects plan quality. In a study of hypofractionated postmastectomy breast radiotherapy, a knowledge-based model was tested with beginner, junior and senior planners on 10 cases.[7] Beginner planners benefited most, with mean heart dose reduced by 13.67 cGy.[7] The authors concluded that the model helps transfer planning skills from senior to beginner planners, improving consistency.[7] Treatment efficiency also improved across all validation datasets, with a reduction of 2.8% to 8.8% in treatment time.[7]

Software changes can introduce quiet variation. When a multi-center prostate model was applied across three planning system versions, significant differences in target metrics appeared in 10 out of 28 plan comparisons and in organ-at-risk metrics in 23 out of 56.[8] The largest variations were minor (≤1.4%), but retraining the model in newer versions improved target coverage and several organ metrics.[8] Patients treated after an upgrade may otherwise receive plans that differ from the validated standard without anyone noticing.

Global evidence reinforces the point. Head and neck planning is among the most time-intensive workflows, particularly in countries like India with a high disease burden.[13] Studies in low- and middle-income settings reported labor savings from automated contouring and guideline-consistent plans from adapted shared models.[14][15] U.S. health systems with rural or network sites face a smaller version of the same challenge. In Guatemala, models developed during 2022–2024 were validated against a 2025 clinical cohort, and model statistics fell within acceptable quality benchmarks.[15]

Trust depends on demonstrating consistency. Executives can ask for plan quality metrics compared across sites, machines and planner groups, and for evidence that models were revalidated after each upgrade. Those comparisons turn equity from an aspiration into a measurable standard.

A medical physicist and a dosimetrist compare a treatment plan against a printed checklist in a quiet workroom.
Illustrative image. Automated contours and plans still require review by experienced professionals.[3]

Human infrastructure

Medical dosimetrists at the center of the planning system

Medical dosimetrists translate clinical intent into deliverable plans. Their work sits between physicians, physicists and therapists, and their time is often the binding constraint on how quickly treatment can begin. Recognizing that role means treating dosimetry capacity as a managed resource, with clear workload measures and protected time for complex cases and training.

Automation changes the shape of dosimetry work. In the breast planning study, a multidisciplinary stakeholder team used improvement science to find the root cause of inefficiency, redesigned the task sequence and introduced automated planning.[1] The approach scaled from a smaller pilot team to the entire clinical workforce.[1] That sequence of pilot, measurement and scaled rollout is a model for introducing new tools without overloading staff.

Cognitive load matters as much as minutes. In the plan check study, task load scores showed notable reductions in effort, frustration and mental demand with script assistance, while performance remained high.[4] Usability scores indicated high learnability and operator confidence.[4] Tools that reduce repetitive checking can protect attention for the judgments that only experienced staff can make. Complex sites such as craniospinal irradiation have traditionally demanded substantial time and expertise from physicians and medical physicists.[11] Those are the cases where protected attention matters most.

Training and skill transfer are workforce strategies in their own right. Knowledge-based planning helped beginner planners produce plans closer to senior quality.[7] Automated workflows still require mandatory review by experienced clinicians.[3] Together these findings suggest a model where new staff learn faster with decision support, while senior dosimetrists spend more time on review, model curation and difficult cases. Recognition can include career paths for dosimetrists who take on model curation, automation review and teaching roles.

The NHS evaluation recommended workflow, capacity and staffing review before and after implementation of AI contouring.[2] Executives can apply that advice directly. Before adopting a new planning tool, leaders can define who will review its outputs, how saved time will be used and how workload will be measured afterward. Without such review, workflow design can keep contouring time savings from reaching the whole pathway.[2] The tongue cancer study noted that manual contouring of multiple organs along with target volumes contributes substantially to planning delays.[13] In the low- and middle-income country network, automated contouring delivered measurable labor cost savings in routine practice.[14]

Executive guidance · Operating dashboard

Review reliability, not campaign activity alone.

Do not publish a number until the organization defines its numerator, denominator where relevant, owner, source system, exclusions, review cadence, and limits. The candidates below are management prompts, not benchmarks or reported results.

Four operating signals

Entry-point clarityOwnership reliabilityPartner-route reliabilityImprovement closure

Each signal pairs an executive question with one candidate local measure, set out below.

Executive guidance · Signal

Entry-point clarity

Can people and staff identify the approved first step without searching across conflicting instructions?

Candidate local measure
Locally defined contact, routing, and repeat-contact signals by channel and service.

Executive guidance · Signal

Ownership reliability

Does a specific team accept each request and make its status visible?

Candidate local measure
Requests without an owner, aged work, transfers, and escalations using locally approved definitions.

Executive guidance · Signal

Partner-route reliability

Do participating teams share one current route and understand who owns each dependency?

Candidate local measure
Locally defined conflicting instructions, unaccepted handoffs, unresolved dependencies, repeat contacts, and partner feedback.

Executive guidance · Signal

Improvement closure

Does the organization correct recurring friction and report what changed?

Candidate local measure
Selected barriers, assigned actions, completion status, and post-change review.

Figure 4

The operating system behind the dashboard

The operating system behind the dashboardThe four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.Accountableoperating route(executive sponsor)Entry-point clarityOwner: Executive sponsor andoperational leadOwnership reliabilityOwner: Operational owner andparticipating teamsPartner-route reliabilityOwner: Sending and receiving ownersImprovement closureOwner: Improvement owner andexecutive sponsor

The four operating signals from this brief’s dashboard, each tied to the candidate owner named in the executive scorecard, around one accountable route. Drawn from the page’s original executive guidance.

Data note. Structural diagram; no measured values.

Limitation. Owners are candidates to be confirmed locally.

Figure data (4 rows)
Figure 4 data: The operating system behind the dashboard
Operating signalCandidate owner
Entry-point clarityExecutive sponsor and operational lead
Ownership reliabilityOperational owner and participating teams
Partner-route reliabilitySending and receiving owners
Improvement closureImprovement owner and executive sponsor

Executive guidance · Handoff workflow

Transfer responsibility with acknowledgment and visibility.

A handoff is reliable only when the sending party knows who is expected to receive the work, the receiving party acknowledges responsibility, and any unresolved exception remains visible. Local policy and qualified judgment control the actual process.

How responsibility moves

Lane AFrom message to accepted ownership4 steps
Lane BFrom accepted ownership to verified follow-through4 steps

Lane A

From message to accepted ownership

  1. Confirm the approved message and intended audience.
  2. Publish the actual entry point and receiving role.
  3. Acknowledge receipt using the locally approved method.
  4. Escalate when ownership or response remains unclear.

Lane B

From accepted ownership to verified follow-through

  1. Record the next accountable owner and visible status.
  2. Name the sending and receiving owners, shared information, current status, and unresolved dependency.
  3. Keep unresolved work visible across boundaries.
  4. Confirm closure or document the continuing exception.

Executive guidance · Executive scorecard

Connect operating signals to accountable executive review.

The scorecard keeps review focused on decisions. Leaders should set definitions locally, examine variation without overclaiming cause, and pair quantitative signals with the experience of people who use and operate the route.

Who reviews what

  • Executive sponsor and operational lead
  • Operational owner and participating teams
  • Sending and receiving owners
  • Improvement owner and executive sponsor

Candidate owners named in the scorecard, confirmed locally.

Candidate questions and ownership assignments. These are not external benchmarks.
Operating signalExecutive questionCandidate ownerSuggested review point
Entry-point clarityCan people and staff identify the approved first step without searching across conflicting instructions?Executive sponsor and operational leadAt campaign launch and close
Ownership reliabilityDoes a specific team accept each request and make its status visible?Operational owner and participating teamsAt a locally defined cadence
Partner-route reliabilityDo participating teams share one current route and understand who owns each dependency?Sending and receiving ownersAt a locally defined cadence
Improvement closureDoes the organization correct recurring friction and report what changed?Improvement owner and executive sponsorUntil action is verified

Figure 5

Control points for a reliable treatment planning system

Figure 5: Control points for a reliable treatment planning system
Control pointRisk if missingOwnerEvidence of control
Turnaround measured from planning scan to first treatmentGains in one step hide delays in anotherRadiation oncology administratorMedian and range of days from scan to first treatment by site
Defined human review for every automated contour and planErrors in serial organs or targets pass unnoticedChief of radiation oncology with chief physicistDocumented review rate and edit categories
Knowledge-based model ownership and revalidationPlans drift from the validated standard after upgradesChief medical physicistRevalidation record for each model after each system change
Risk-targeted patient-specific quality assuranceMeasurement effort spread evenly while complex plans carry most riskMedical physics quality leadShare of high-complexity plans receiving full measurement
Visible task board across planning rolesHandoffs wait without an owner or due timeDosimetry supervisorShare of planning tasks with an assigned owner and due date
Cross-site plan quality comparisonPatients at network sites receive less consistent plansQuality committee for radiation oncologyPlan quality metrics by site, machine and planner group

Control points derived from the cited evidence [2], [3], [5], [6], [8], [10], [13] and this brief’s executive guidance.

Data note. Each row is a control to verify, not a measured result.

Limitation. Owners and evidence of control must follow local policy and applicable requirements.

Public communication

Communicating about planning, automation and safety

Patients and families increasingly hear that artificial intelligence is used in their care. Public communication about radiation therapy planning should explain that automated tools draft contours or plans, and that qualified professionals review and approve them. The prostate automation study framed this as a draft-first approach with mandatory physician review.[3] That framing is accurate and reassuring. Patients may also ask whether plans are consistent across locations. Explaining that plans follow shared institutional standards and are checked before treatment is accurate only when the organization can show it with data.

Messages should avoid promising speed the system cannot deliver. Contouring time can fall sharply while the full pathway from scan to treatment changes little, as the NHS evaluation found.[2] Organizations can describe planning improvements in terms of what has been measured locally, such as the share of plans completed within a defined window, rather than vendor claims. Where contour acceptability is strongest, as with breast contours in the NHS evaluation, organizations may choose to introduce new tools first.[2]

Internal communication is equally important. The in-house platform study described improved task hand-off, centralized daily role and contact information and a whiteboard that consolidated planning metadata.[6] The authors cautioned that such tools must be guided by institutional oversight and formal quality management to ensure data security and compliance.[6] Planning teams need both the visibility and the governance. The plan check study reported high usability and operator confidence, which leaders can share as evidence that new tools were tested with the people who use them.[4]

Model governance should be communicated clearly to staff. The version upgrade study confirmed the vendor recommendation to re-extract and retrain knowledge-based models when a planning system upgrade is undertaken.[8] Change notices that tell dosimetrists and physicists which models were revalidated, and when, reduce uncertainty and support safe practice. Similar notices can explain when a refinement layer or shared model is introduced, what it changes and how its plans are reviewed.

On National Medical Dosimetrist Day, recognition is most meaningful when it is tied to the system dosimetrists operate. Leaders can thank planning teams while also sharing what the organization will change: clearer queues, better tools, defined review rules and measured turnaround. That message connects appreciation with accountability.

Dosimetrists, therapists and a physicist hold a brief morning huddle with coffee around a workroom table.
Illustrative image. AI-assisted contouring reduced contouring time, but workflow design limited savings across the whole planning pathway.[2]

Executive guidance · 90-day plan

Use 90 days to correct one visible operating barrier.

The time boxes below are a management framework, not a clinical timeline. Adjust them to risk, scope, governance, resources, stakeholder participation, and applicable review requirements.

Ninety days, three moves

  1. Days 1–30See the current route
  2. Days 31–60Build the reliable path
  3. Days 61–90Make the change visible

Days 1–30 · Listen and map

See the current route

  • Name an executive sponsor and an operational owner.
  • Listen to people using the route and representative frontline teams.
  • Map how National Medical Dosimetrist’s Day communications connect to real entry points, owners, transitions, and escalation.
  • Select one recurring barrier that the organization can responsibly address.

Days 31–60 · Design and test

Build the reliable path

  • Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
  • Validate the design with every sending and receiving team involved.
  • Test one internal or partner handoff and correct a verified communication, dependency, or ownership gap.
  • Test the route in more than one representative setting or operating period where practical.

Days 61–90 · Implement and verify

Make the change visible

  • Launch the redesigned route with a small set of locally defined measures.
  • Review unresolved work and recurring friction using a learning approach.
  • Correct implementation barriers and record who owns each remaining dependency.
  • Report what changed, what evidence was reviewed, and what still requires live oversight.

Figure 6

The 90-day plan on one timeline

The 90-day plan on one timelineThe 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.Day 0Day 30Day 60Day 90Name an executive sponsor and an operational owner.Days 1–30: Name an executive sponsor and an operational owner.Listen to people using the route and representative frontlineteams.Days 1–30: Listen to people using the route and representative frontline teams.Map how National Medical Dosimetrist’s Day communicationsconnect to real entry points, owners, transitions, andescalation.Days 1–30: Map how National Medical Dosimetrist’s Day communications connect to real entry points, owners, transitions, and escalation.Select one recurring barrier that the organization canresponsibly address.Days 1–30: Select one recurring barrier that the organization can responsibly address.Define the trigger, receiving owner, required information,acknowledgment, escalation, and closure signal.Days 31–60: Define the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.Validate the design with every sending and receiving teaminvolved.Days 31–60: Validate the design with every sending and receiving team involved.Test one internal or partner handoff and correct a verifiedcommunication, dependency, or ownership gap.Days 31–60: Test one internal or partner handoff and correct a verified communication, dependency, or ownership gap.Test the route in more than one representative setting oroperating period where practical.Days 31–60: Test the route in more than one representative setting or operating period where practical.Launch the redesigned route with a small set of locallydefined measures.Days 61–90: Launch the redesigned route with a small set of locally defined measures.Review unresolved work and recurring friction using a learningapproach.Days 61–90: Review unresolved work and recurring friction using a learning approach.Correct implementation barriers and record who owns eachremaining dependency.Days 61–90: Correct implementation barriers and record who owns each remaining dependency.Report what changed, what evidence was reviewed, and whatstill requires live oversight.Days 61–90: Report what changed, what evidence was reviewed, and what still requires live oversight.Listen and mapDesign and testImplement and verify

The 90-day plan from this brief drawn as a timeline: each action sits in the 30-day window the plan assigns it. The full wording of each action is in the figure data and in the plan above.

Data note. Time boxes are a management framework, not a clinical timeline.

Limitation. Durations are uniform 30-day windows; real tasks may span windows.

Figure data (12 rows)
Figure 6 data: The 90-day plan on one timeline
WindowAction
Days 1–30 · Listen and mapName an executive sponsor and an operational owner.
Days 1–30 · Listen and mapListen to people using the route and representative frontline teams.
Days 1–30 · Listen and mapMap how National Medical Dosimetrist’s Day communications connect to real entry points, owners, transitions, and escalation.
Days 1–30 · Listen and mapSelect one recurring barrier that the organization can responsibly address.
Days 31–60 · Design and testDefine the trigger, receiving owner, required information, acknowledgment, escalation, and closure signal.
Days 31–60 · Design and testValidate the design with every sending and receiving team involved.
Days 31–60 · Design and testTest one internal or partner handoff and correct a verified communication, dependency, or ownership gap.
Days 31–60 · Design and testTest the route in more than one representative setting or operating period where practical.
Days 61–90 · Implement and verifyLaunch the redesigned route with a small set of locally defined measures.
Days 61–90 · Implement and verifyReview unresolved work and recurring friction using a learning approach.
Days 61–90 · Implement and verifyCorrect implementation barriers and record who owns each remaining dependency.
Days 61–90 · Implement and verifyReport what changed, what evidence was reviewed, and what still requires live oversight.

Executive guidance · Leadership close

Pair recognition with a system people can trust.

Recognition matters. It becomes durable when leaders also listen, clarify the route, support the people operating it, close an identified gap, and report the result without claiming more than the evidence supports.

Leadership commitment

Connect the message to one usable, measured, and sustained operating change.

Executive action kit · Day observance

Turn National Medical Dosimetrist’s Day into accountable action.

Move from recognition activity to a visible operating route with named owners and closed loops.

Take it with you

Filed under

Public Health and PreventionDay

Leadership focus

Use this observance to examine trustworthy information, prevention access, and community connection. Select one verified barrier, assign an accountable owner, and carry the improvement beyond the campaign window.

Workforce lens

Ask whether staffing, role clarity, training, tools, workload, and escalation support the people operating the information, access, coordination, and follow-through pathway.

Patient and community lens

Make the approved first step clear. Test whether a person can move from information to an acknowledged next action without navigating conflicting instructions.

Equity and access lens

Review language, disability, transportation, digital access, geography, trust, and other barriers using protected feedback and locally appropriate data.

Five-minute briefing

Inspect the operating sequence

Listen with people using the pathway, frontline teams, operational leaders, and community partners. Find one a message, request, referral, or handoff that does not reach an accountable owner, then test the locally approved route from entry through acknowledged follow-through.

  1. Listen
  2. Clarify entry
  3. Coordinate the partner route
  4. Protect transitions
  5. Verify and learn
Leadership actions for this week
  • Name an executive sponsor and frontline operating owner.
  • Ask people using and operating the pathway where ownership becomes unclear.
  • Test one representative route from first question to acknowledged next step.
  • Select one barrier that can be corrected without overstating the evidence.
  • Set a review date and define how completion will be verified.
Candidate measures

Define every numerator, denominator where relevant, owner, data source, exclusions, cadence, and limitation locally. These are management prompts, not external benchmarks.

  • Locally defined contact, routing, and repeat-contact signals by channel and service.
  • Requests without an owner, aged work, transfers, and escalations using locally approved definitions.
  • Locally defined conflicting instructions, unaccepted handoffs, unresolved dependencies, repeat contacts, and partner feedback.
Department readiness checklist
  • The public and staff entry points match the actual approved process.
  • A specific role accepts each request, referral, or escalation.
  • Handoffs include acknowledgment and a visible unresolved state.
  • Language, disability, digital, transportation, and trust barriers receive explicit review.
  • Communications do not introduce unsupported themes, statistics, or clinical advice.
  • A named leader will review what changed after the observance.
Intended audiences
  • Executive and Operational Leaders
  • Public Health and Community Partners
Staff communication template

During National Medical Dosimetrist’s Day, our organization will connect awareness with a practical review of the information, access, coordination, and follow-through pathway. Use approved information, identify the correct entry point, confirm ownership when work moves, protect privacy, and escalate unresolved barriers through local channels.

Community communication template

National Medical Dosimetrist’s Day is an opportunity to share trustworthy information and make the next step easier to find. Use our approved channels for information and support. If a request changes hands, our goal is to keep ownership and follow-through visible.

Measurement worksheet
Signal
What observable condition will show whether the route works?
Definition
What is included, excluded, and counted?
Owner
Who reviews the signal and acts on exceptions?
Cadence
When will leaders review it?
Equity check
Which differences require protected, locally appropriate review?
Closure
What evidence will confirm the improvement was completed?
Editorial review
Completed
Source records
2 listed under Authoritative resources
Review standard
Sourced facts remain separated from original executive guidance
Clinical boundary
No new statistical or clinical claim was added by this action kit

Sources and content boundary

Authoritative resources

Use note: All operating models, measures, scorecard questions, and action steps are original executive guidance. This article supports leadership planning and education. It does not replace clinical judgment, emergency procedures, legal advice, professional standards, organizational policy, or applicable federal, state, and local requirements.

Peer-reviewed references

References

Fifteen peer-reviewed sources, newest first. Each was individually verified through authenticated academic research databases. Bracketed numbers in the text link here; the original executive guidance on this page carries no citations because it is guidance, not a sourced claim. Sources last checked in those databases on .

  1. 1. Quality Improvement and Process Redesign for the Clinical Integration of Automated Breast Radiation Therapy Planning. Practical Radiation Oncology. 2026;16(3):e253-e263. https://doi.org/10.1016/j.prro.2025.10.019
  2. 2. A multi-centre real-world evaluation of AI-assisted organ at risk contouring on radiotherapy treatment planning workflows. The British Journal of Radiology. 2026;99(1184):1615-1623. https://doi.org/10.1093/bjr/tqag111
  3. 3. Prospective blinded clinical evaluation of a fully automated workflow for prostate radiotherapy. Physics and Imaging in Radiation Oncology. 2026;39. https://doi.org/10.1016/j.phro.2026.100999
  4. 4. Clinical impact of introducing automated plan checking in radiation therapy: effects on workflow efficiency, cognitive load and usability. Journal of Radiation Research. 2026. https://doi.org/10.1093/jrr/rrag078
  5. 5. Optimizing Patient-specific Quality Assurance Workload with Neural Network Analysis of Log Files and Complexity Indices. Journal of Medical Physics. 2026;51(1):191-198. https://doi.org/10.4103/jmp.jmp_265_25
  6. 6. Four-year experience with an in-house treatment management platform to streamline departmental operations in radiation oncology. Journal of Applied Clinical Medical Physics. 2026;27(3):e70515. https://doi.org/10.1002/acm2.70515
  7. 7. Establishing a knowledge-based planning model for left-sided breast cancer patients receiving hypofractionated postmastectomy and regional nodal irradiation. Medical Dosimetry. 2026;51(1):11-17. https://doi.org/10.1016/j.meddos.2025.06.001
  8. 8. Version upgrades in treatment planning Systems affect clinical application of a multi-Centre knowledge-based planning model. Technical Innovations & Patient Support in Radiation Oncology. 2026;39. https://doi.org/10.1016/j.tipsro.2026.100417
  9. 9. Improving portability of knowledge-based planning using an LLM-driven plan refinement framework in lung radiotherapy. Medical Physics. 2026;53(9):e70657. https://doi.org/10.1002/mp.70657
  10. 10. Optimization of Automated Radiotherapy Planning for Head and Neck Cancers and Brain Tumors Using Knowledge-Based Planning Models. Cancers. 2026;18(14):2216. https://doi.org/10.3390/cancers18142216
  11. 11. An optimized knowledge-based planning method for craniospinal irradiation integrated with auto-contouring. Physica Medica. 2026;143. https://doi.org/10.1016/j.ejmp.2026.105743
  12. 12. Feasibility of using geometry-based synthetic dose distributions for Knowledge-based planning model training. Physica Medica. 2026;145. https://doi.org/10.1016/j.ejmp.2026.105763
  13. 13. Clinical and Geometric Evaluation of AI-Based Organ at Risk Auto-Contouring for Post -operative Oral Tongue Cancer Radiotherapy: Accuracy, Dosimetric Safety and Workflow Efficiency. Clinical Oncology. 2026. https://doi.org/10.1016/j.clon.2026.104344
  14. 14. Economics achieved through the use of artificial intelligence–powered contouring solutions in a network of oncology clinics in low- and middle-income countries. Frontiers in Oncology. 2026:1-4. https://doi.org/10.3389/fonc.2026.1809864
  15. 15. Retrospective Analysis of a WashU-Based Knowledge-Based Planning (KBP) Model for Breast and Chest Wall Planning in Guatemala: Compliance With American Society for Radiation Oncology (ASTRO) 2026 Guidelines. Cureus. 2026;18(6):e110611. https://doi.org/10.7759/cureus.110611

Claim-to-source matrix

What each source supports

Every sourced claim in the new sections maps to the references that support it, the section where it is used, and the limitation a reader should keep in mind. Original executive guidance carries no sources because it is guidance, not a finding.

Claim-to-source matrix
Claim groupSourcesYearsUsed inLimitation
Process redesign and automated breast planning[1]2026Executive openingSingle program from 2020 to 2022; breast planning only.
AI-assisted contouring across NHS departments[2]2026Current evidenceEight departments with differing workflows; time savings not seen across the whole pathway.
Fully automated prostate workflow acceptability[3]2026Current evidenceTwenty-two patients at one center; physician review required.
Automated contouring and planning in complex sites[11] [13]2026Current evidenceSingle-center studies; serial organs and target hotspots need manual review.
Automated plan checking and physicist workload[4]2026Continuum of careFour physicists and nine cases in one department.
Targeted patient-specific quality assurance[5]2026Continuum of careDepends on linac calibration; moderate sensitivity and specificity.
Department coordination platform[6]2026Continuum of careIn-house tool at one large department; outcomes based on task duration and surveys.
Knowledge-based planning for resource-limited centers[12] [15]2026AccessRetrospective dosimetric studies; synthetic data and adapted models need local validation.
Labor cost savings from automated contouring[14]2026AccessCost scenarios in one low- and middle-income country network.
Portability of knowledge-based models[9]2026AccessSixty-two retrospective lung cases; early-stage method.
Standardization across sites and planner experience[7] [10]2026Equity and trustRetrospective single-institution models; patient-level overlap in validation.
Planning system upgrades and model performance[8]2026Equity and trustTwenty prostate patients and one vendor system.
Greg Wahlstrom in his office at The Healthcare Executive

About the author

Greg Wahlstrom

MBAHCM

President and Chief Executive Officer, The Healthcare Executive

©2014 – 2026 The Healthcare Executive. All rights reserved.

Back to the contents

Health Observance Calendar

See next month’s observances before it starts.

One email ahead of each month with the health observances coming up and the executive briefs that go with them.

Sent by The Healthcare Executive. Unsubscribe at any time. See our Privacy Policy.